CHICAGO, IL (October 7, 2005) – PharmaNutrients, a leading research and development company and supplier of proprietary, science-based nutritional ingredients, today announced the positive outcome of ConsumerLab.com testing of its CLA One® brand of CLA conjugated linoleic acid (www.claone.com).

Dr. Tod Cooperman, President of ConsumerLab.com stated, “It is refreshing to see a raw material producer like PharmaNutrients willing to take the extra step to test their product.  This provides end consumers and supplement manufactures the extra assurance that CLA One® is proven to have passed this rigorous test.

ConsumerLab.com determined that CLA One® met their CL Quality Standard. CLA One® was tested in an independent laboratory blinded to the product’s identity. CLA One® is now the only brand of CLA raw material to undergo CL’s rigorous criteria. To view the test results, visit www.consumerlab.com/results/rawing.asp

Dr. Susie Rockway, Director of Research and Development at PharmaNutrients, stated,
“We have been producing a pure, consistent isomer profile for CLA for years, and it is rewarding to have ConsumerLab.com confirm our product’s integrity.  Our consistency of the 80% CLA One® has been the gold standard and we are proud of the high level of quality assurance that goes into manufacturing these fatty acids.” 

Mark Nottoli, President and founder of PharmaNutrients stated, “ConsumerLab.com test results is further confirmation of CLA One’s high quality. With GMP production we ensure pure, consistent quality and a reliable source, available for immediate delivery.”

Nottoli further explained, “While CLA is available from some Chinese suppliers, these are of unknown quality and put companies at risk for violating the numerous patents covering the use of CLA.” 

PharmaNutrients’ CLA One® provides rights to the various WARF patents and the right to make patent claims.

About PharmaNutrients, Inc.:

Dedicated to creating products to enhance wellness, PharmaNutrients (www.pharmanutrients.com) supports research investigating fatty acids and soluble fibers. The company's activities encompass multiple technology platforms focused on creating solutions for obesity-related health issues including weight management, inflammation, diabetes and cardiovascular health. PharmaNutrients’ conjugated linoleic acid and chitosan-based products are used in a wide range of dietary supplements.

PharmaNutrients is recognized for creating Tonalin CLA, the first nutritional dietary supplement targeted at “Body Composition” and creating the “Fat Binding” category with Absorbitol brand chitosan complex.  Since its de-merger with Natural ASA of Norway in 1999, PharmaNutrients has further developed new applications for CLA beyond weight management with numerous patents.